Integra Lifesciences Holdings (IART) Net Margin (2009 - 2026)

Integra Lifesciences Holdings (IART) has 17 years of Net Margin data on file, last reported at 1.18% in Q1 2026.

• For the quarter ending Q1 2026, Net Margin rose 543.0% year-over-year to 1.18%; the trailing twelve-month figure through Mar 2026 stood at 30.15% (down 2837.0% YoY), and the FY2025 full-year result was 31.58%, down 3115.0% from the prior year.
• Net Margin fell to 1.18% in Q1 2026, from 0.39% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 13.3% in Q4 2022 to a low of 116.47% in Q2 2025.
• A 5-year average of 3.79% and a median of 1.1% in 2023 frame the typical range for Net Margin.
• Across the five-year window, Net Margin sank 11351 bps in 2025 and jumped 543 bps in 2026, its largest moves.
• Tracing IART's Net Margin over 5 years: stood at 13.3% in 2022, then sank by 62 bps to 5.0% in 2023, then fell by 12 bps to 4.39% in 2024, then slumped by 109 bps to 0.39% in 2025, then sank by 201 bps to 1.18% in 2026.
• Business Quant data shows IART's Net Margin at 1.18% in Q1 2026, 0.39% in Q4 2025, and 1.34% in Q3 2025.